These images are provided for non-commercial use under a Creative Commons License (BY-NC-ND). To license a high resolution version, please contact our image library who will discuss fees, terms and waivers.
Download this imageCreative commons explained - what it means, how you can use our's and other people's content.
The death of Alcestis
Draughtsman: Masreliez, Louis Adrien
Given by Daniel Katz in honour of the Directorship of Simon Jervis
Height: 256 mm
Width: 355 mm
Method of acquisition: Given (1995) by Daniel Katz Ltd
Production date: before AD 1784 : Watermark: grapes
Support composed of laid paper
Drawing : Pen and black ink with grey wash over graphite on laid paper
Accession number: PD.390-1995
Primary reference Number: 37817
Stable URI
Owner or interested party:
The Fitzwilliam Museum
Associated department:
Paintings, Drawings and Prints
This record can be cited in the Harvard Bibliographic style using the text below:
The Fitzwilliam Museum (2024) "The death of Alcestis" Web page available at: https://collection.beta.fitz.ms/id/object/37817 Accessed: 2024-04-19 07:26:25
To cite this record on Wikipedia you can use this code snippet:
{{cite web|url=https://collection.beta.fitz.ms/id/object/37817
|title=The death of Alcestis
|author=The Fitzwilliam Museum|accessdate=2024-04-19 07:26:25|publisher=The
University of Cambridge}}
To call these data via our API (remember this needs to be authenticated) you can use this code snippet:
https://collection.beta.fitz.ms/api/v1/objects/object-37817
To use this as a simple code embed, copy this string:
<div class="text-center">
<figure class="figure">
<img src="https://data.fitzmuseum.cam.ac.uk/imagestore/pdp/pdp13/PD_390_1995.jpg"
alt="The death of Alcestis"
class="img-fluid" />
<figcaption class="figure-caption text-info">The death of Alcestis</figcaption>
</figure>
</div>
Accession Number: M.21B-1938
Accession Number: CM.100-1994
Accession Number: M.6-1939
Accession Number: M.21A-1938
Updates about future exhibitions and displays, family activities, virtual events & news. You'll be the first to know...
